CJC/IPA
CJC/IPA is a research blend pairing CJC no DAC (a GHRH receptor agonist) with Ipamorelin (a selective GHS-R1a agonist) in a single lyophilized preparation. The two peptides act on distinct receptor subtypes to engage complementary arms of somatotroph signaling: CJC no DAC drives the cAMP-PKA cascade while Ipamorelin activates the phospholipase C pathway. Combination preparations are used in GH-axis research to study synergistic receptor crosstalk in pituitary cell models. Supplied lyophilized for in vitro research use only.
Select size
$75.00
- CAS
- Blend
- MW
- Mixed
- Formula
- Blend
- Purity
- >=99.0 HPLC
- Storage
- -20 °C, lyophilized
Research Notes
What is CJC/IPA?
CJC/IPA is a synthetic research compound studied in laboratory settings. It is intended for in vitro research use only and is not for human or animal use.
What purity is AminoKinetics's CJC/IPA?
AminoKinetics supplies CJC/IPA at >=99.0% purity, verified by third-party HPLC analysis. A certificate of analysis is available on request.
How is CJC/IPA supplied?
CJC/IPA is supplied as a lyophilized powder in sealed research-grade vials, stored -20 °C, lyophilized, intended for in vitro and laboratory research use only.